1 / 6

Cataract Therapeutic Development Review H1 2015

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities.

jack2222simon
Download Presentation

Cataract Therapeutic Development Review H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cataract - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Markets Direct Date: 20-May-2015 No. of pages: 50 Single User License: US $2000 Browse more Reports on Ophthalmology Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ophthalmology-therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Cataract - Pipeline Review, H1 2015 This report gives complete data on the helpful advancement for Cataract, complete with similar investigation at different stages, therapeutics appraisal by medication target, system of activity (MoA), course of organization (RoA) and particle sort, alongside most recent overhauls, and highlighted news and press discharges. It likewise audits key players included in the restorative improvement for Cataract and extraordinary elements on late-stage and ceased ventures. The report improves choice making capacities and help to make viable counter techniques to increase game changer. It fortifies R&D pipelines by recognizing new targets and MOAs to create first-in-class and best-in-class items. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Cataract - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research : CalAsia Pharmaceuticals, Inc., EyeGate Pharmaceuticals, Inc., InSite Vision Incorporated, Laboratorios Sophia S.A. de C.V., Laila Pharmaceuticals Pvt. Ltd., Omeros Corporation and R-Tech Ueno, Ltd. Drugs Profile Discussed in this Research : (bromfenac sodium + dexamethasone acetate), (sulfasalazine + Hyaluronic Acid), dexamethasone acetate, LP-01309PRO-155, RTU-007, Small Molecule to Antagonize GPR161 for Metastatic Epithelial Cancers, Congenital Cataracts and Birth Defects of the Brain and Spinal Cord, Small Molecule to Inhibit NFkB for Ophthalmology, Oncology and Immunology, Small Molecules for Non-Surgical Cataracts and Multiple Sclerosis, Small Molecules for Ophthalmology and CNS Disorders and Small Molecules for Ophthalmology, Cardiovascular, CNS and Metabolic Disorders. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Cataract - Pipeline Review, H1 2015 Scope For Cataract - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Cataract • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Cataract and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Cataract products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages • A detailed assessment of monotherapy and combination therapy pipeline projects ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Cataract - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Cataract • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Cataract pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Cataract - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related